English English | 中文 中文

Bioactive Peptides in Metabolic Syndrome

Metabolic syndrome refers to a cluster of risk factors for cardiovascular diseases and type 2 diabetes including elevated waist circumference (WC), elevated triglycerides, reduced high-density lipoprotein, elevated fasting glucose, and elevated blood pressure. The prevalence of MetS is high and increasing rapidly worldwide. Improved understanding the pathophysiology of MetS and the characterization of novel targets to mitigation of the risks over the past decades have shed light on combating this disorder.

Bioactive peptides derived from food proteins hold great promise for the prevention and management of many chronic diseases as functional foods and/or nutraceuticals, since their use offers many advantages, including safety, good efficacy and selectivity, and low health cost.

In literature, there is ample studies on the potential benefits of bioactive peptides on anti-hypertension, and anti-oxidative stress; reports on the potential and mechanistic characterization of bioactive peptides on obesity, glucose and lipid metabolism, and insulin resistance, is emerging. Recently, it has been also suggested that bioactive peptides show an intrinsically multifunctional behavior exerting more than one of the physiological effects above mentioned.

We invite submission of original research articles and comprehensive reviews aiming to evaluate the potential of bioactive peptides against metabolic syndrome, structure and activity relationship, as well as mechanistic assessment.

 

Potential topics include but are not limited to the follows:

  • Preparation, characterization and bioinformatics study of bioactive peptides from food proteins
  • Human, animal and cell studies assessing the activity and mechanisms of bioactive peptides
  • Identification and characterization of novel molecular targets of bioactive peptides
  • Structure and activity relationship study of bioactive peptides against metabolic syndrome
  • Regulation and product development using bioactive peptides against metabolic syndrome.

 

Instructions for submission:

  • The Elsevier Editorial System is ready for article submission towards the Virtual special issue SI: Bioactive Peptides
  • The submission website for this journal is located at:  https://www.evise.com/evise/faces/pages/navigation/NavController.jspx?JRNL_ACR=FSHW
  • To ensure that all manuscripts are correctly included into the special issue, it is important that authors select SI: Bioactive Peptides when they reach the “Article Type” step in the submission process.

 

Benefits of publishing with Food Science and Human Wellness:

  • Free-of-charge for Open access (unlimited and free access for readers, and high visibility on Science Direct).
  • Indexed by Inclusion in various databases (SCIE, ESI, Scopus, FSTA, DOAJ,CCABES, CCCM)
  • Mock impact factor (IF) is 2.25 (impact factor is expected in 2020)

 

Guest Co-Editors

  • Dr. Jianping Wu, Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada 
  • Dr. Lammi Carmen, Department of Pharmaceutical Sciences, University of Milan, via Mangiagalli 25, 20133-Milano, Italy

 

Submission Deadline: October 30, 2020

Share this page: